275 related articles for article (PubMed ID: 38600608)
1. Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma.
Cheng Y; Song Z; Fang X; Tang Z
Clin Epigenetics; 2024 Apr; 16(1):54. PubMed ID: 38600608
[TBL] [Abstract][Full Text] [Related]
2. EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.
Chang JW; Gwak SY; Shim GA; Liu L; Lim YC; Kim JM; Jung MG; Koo BS
Oral Oncol; 2016 Jan; 52():66-74. PubMed ID: 26604082
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.
Gannon OM; Merida de Long L; Endo-Munoz L; Hazar-Rethinam M; Saunders NA
Clin Cancer Res; 2013 Jan; 19(2):428-41. PubMed ID: 23186778
[TBL] [Abstract][Full Text] [Related]
4. The competitive mechanism of EZH1 and EZH2 in promoting oral squamous cell carcinoma.
Chen J; Tang S; Zheng Q; Li J; Jiang H; Lu H; Liao G; Li K; Liang Y
Exp Cell Res; 2024 Mar; 436(1):113957. PubMed ID: 38309675
[TBL] [Abstract][Full Text] [Related]
5. Role of EZH2 in oral squamous cell carcinoma carcinogenesis.
Zhao L; Yu Y; Wu J; Bai J; Zhao Y; Li C; Sun W; Wang X
Gene; 2014 Mar; 537(2):197-202. PubMed ID: 24424512
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
[TBL] [Abstract][Full Text] [Related]
7. Targeting of EZH2 inhibits epithelial‑mesenchymal transition in head and neck squamous cell carcinoma via regulating the STAT3/VEGFR2 axis.
Zhao M; Hu X; Xu Y; Wu C; Chen J; Ren Y; Kong L; Sun S; Zhang L; Jin R; Zhou X
Int J Oncol; 2019 Nov; 55(5):1165-1175. PubMed ID: 31545422
[TBL] [Abstract][Full Text] [Related]
8. Targeting EZH2 regulates tumor growth and apoptosis through modulating mitochondria dependent cell-death pathway in HNSCC.
Zhou X; Ren Y; Kong L; Cai G; Sun S; Song W; Wang Y; Jin R; Qi L; Mei M; Wang X; Kang C; Li M; Zhang L
Oncotarget; 2015 Oct; 6(32):33720-32. PubMed ID: 26378043
[TBL] [Abstract][Full Text] [Related]
9. EZH2 knockout in oral cavity basal epithelia causes more invasive squamous cell carcinomas.
Baquero J; Tang XH; Scognamiglio T; Gudas LJ
Carcinogenesis; 2021 Dec; 42(12):1485-1495. PubMed ID: 34614148
[TBL] [Abstract][Full Text] [Related]
10. Targeting EZH2 and PRC2 dependence as novel anticancer therapy.
Xu B; Konze KD; Jin J; Wang GG
Exp Hematol; 2015 Aug; 43(8):698-712. PubMed ID: 26027790
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation.
Mochizuki D; Misawa Y; Kawasaki H; Imai A; Endo S; Mima M; Yamada S; Nakagawa T; Kanazawa T; Misawa K
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469511
[TBL] [Abstract][Full Text] [Related]
12. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
[TBL] [Abstract][Full Text] [Related]
13. Role of the EZH2/miR-200 axis in STAT3-mediated OSCC invasion.
Wang Y; Guo W; Li Z; Wu Y; Jing C; Ren Y; Zhao M; Kong L; Zhang C; Dong J; Shuang Y; Sun S; Chen J; Wu C; Qiao Y; Qu X; Wang X; Zhang L; Jin R; Zhou X
Int J Oncol; 2018 Apr; 52(4):1149-1164. PubMed ID: 29532870
[TBL] [Abstract][Full Text] [Related]
14. A Noncanonical Function of Polycomb Repressive Complexes Promotes Human Cytomegalovirus Lytic DNA Replication and Serves as a Novel Cellular Target for Antiviral Intervention.
Svrlanska A; Reichel A; Schilling EM; Scherer M; Stamminger T; Reuter N
J Virol; 2019 May; 93(9):. PubMed ID: 30814291
[TBL] [Abstract][Full Text] [Related]
15. Nuclear localization signal-enhanced RNA interference of EZH2 and Oct4 in the eradication of head and neck squamous cell carcinoma-derived cancer stem cells.
Lo WL; Chien Y; Chiou GY; Tseng LM; Hsu HS; Chang YL; Lu KH; Chien CS; Wang ML; Chen YW; Huang PI; Hu FW; Yu CC; Chu PY; Chiou SH
Biomaterials; 2012 May; 33(14):3693-709. PubMed ID: 22361100
[TBL] [Abstract][Full Text] [Related]
16. EZH2 overexpression in head and neck cancer is related to lymph node metastasis.
Nienstedt JC; Schroeder C; Clauditz T; Simon R; Sauter G; Muenscher A; Blessmann M; Hanken H; Pflug C
J Oral Pathol Med; 2018 Mar; 47(3):240-245. PubMed ID: 29285811
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2.
Christofides A; Karantanos T; Bardhan K; Boussiotis VA
Oncotarget; 2016 Dec; 7(51):85624-85640. PubMed ID: 27793053
[TBL] [Abstract][Full Text] [Related]
18. Genistein nanoformulation promotes selective apoptosis in oral squamous cell carcinoma through repression of 3PK-EZH2 signalling pathway.
Dev A; Sardoiwala MN; Kushwaha AC; Karmakar S; Choudhury SR
Phytomedicine; 2021 Jan; 80():153386. PubMed ID: 33113500
[TBL] [Abstract][Full Text] [Related]
19. Snail and Slug collaborate on EMT and tumor metastasis through miR-101-mediated EZH2 axis in oral tongue squamous cell carcinoma.
Zheng M; Jiang YP; Chen W; Li KD; Liu X; Gao SY; Feng H; Wang SS; Jiang J; Ma XR; Cen X; Tang YJ; Chen Y; Lin YF; Tang YL; Liang XH
Oncotarget; 2015 Mar; 6(9):6797-810. PubMed ID: 25762643
[TBL] [Abstract][Full Text] [Related]
20. Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma.
Wang C; Liu X; Chen Z; Huang H; Jin Y; Kolokythas A; Wang A; Dai Y; Wong DT; Zhou X
Mol Carcinog; 2013 Mar; 52(3):229-36. PubMed ID: 22161744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
